US46266C1053
© BusinessWire
22.01.2026
IQV
LISTED
NYSE
IQVIA Named to the Fortune® World’s Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2026 Fortune® World’s Most Admired Companies™ list.
This is the fifth year in a row IQVIA has earned first place in the Health Care: Pharmacy and Other Services category, and the ninth...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2026
IQV
LISTED
NYSE
IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its fourth-quarter and full-year 2025 financial results before the market opens on Thursday, February 5, 2026. The IQVIA management team wil...
Themefolio
Profiler
Peergroup
© BusinessWire
02.12.2025
IQV
LISTED
NYSE
IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform
News Preview
IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic collaboration with Amazon Web Services (AWS), naming AWS as IQVIA’s Preferred Agentic Cloud Provider. The partnership, revealed at AWS re:Invent, is...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
05.11.2025
IQV
LISTED
NYSE
Dr. William G. Kaelin Jr. joins IQVIA Board of Directors
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced the appointment of Dr. William G. Kaelin Jr. to its board of directors, effective today.
Dr. Kaelin is a Senior Physician-Scientist at Brigham and Women’s Hospital in Boston and the Sidney Farber Professor of Medic...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© BusinessWire
28.10.2025
IQV
LISTED
NYSE
IQVIA Reports Third-Quarter 2025 Results
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended September 30, 2025.
Third-Quarter 2025 Operating Results
Revenue for the third quarter of $4,10...
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2025
IQV
LISTED
NYSE
IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Ari Bousbib, chairman and chief executive officer, will speak at the UBS Global Healthcare Conference on Tuesday, November 11, 2025 a...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
IQV
LISTED
NYSE
IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its third-quarter 2025 financial results before the market opens on Tuesday, October 28, 2025. The IQVIA management team will also host a co...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
IQV
LISTED
NYSE
IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has been honored with the WCG Pinnacle Award for Site Relationships in Professionalism and Communication. The award recognizes IQVIA’s commitment to building strong, collaborativ...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
IQV
LISTED
NYSE
IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced the launch of its Clinical Trial Financial Suite (CTFS), an AI-enabled platform orchestrating all financial aspects of clinical trials. CTFS is designed to elimin...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
IQV
LISTED
NYSE
IQVIA Announces CFO Transition in Early 2026
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences and healthcare industries, today announced a planned leadership transition in its finance organization. Michael Fedock, currently Senior Vice President of Financial Planning & Anal...
Themefolio
Profiler
Peergroup
© PR Newswire
28.08.2025
IQV
LISTED
NYSE
IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies
News Preview
RESEARCH TRIANGLE PARK, N.C. and CAMBRIDGE, Mass., Aug. 28, 2025 /PRNewswire/ -- IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, and Flagship Pioneering, the bioplatform innovation company, today announced a strategic collaboration to accelerate the development of breakt...
Themefolio
Profiler
Peergroup
© PR Newswire
11.08.2025
IQV
LISTED
NYSE
Kexing Biopharm Enters Strategic Partnership with IQVIA to Accelerate Global Expansion
News Preview
SHENZHEN, China, Aug. 11, 2025 /PRNewswire/ -- Kexing Biopharm (688136.SH) has officially entered into a comprehensive strategic partnership with IQVIA(NYSE:IQV), a global leader in clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. The partnership aims to accelerate the glo...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
22.07.2025
IQV
LISTED
NYSE
IQVIA Reports Second-Quarter 2025 Results
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended June 30, 2025.
Second-Quarter 2025 Operating Results
Revenue for the second quarter of $4,017 m...
Themefolio
Profiler
Peergroup
© BusinessWire
01.07.2025
IQV
LISTED
NYSE
IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its second-quarter 2025 financial results before the market opens on Tuesday, July 22, 2025. The IQVIA management team will also host a conf...
Themefolio
Profiler
Peergroup
© BusinessWire
16.06.2025
IQV
LISTED
NYSE
IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has been selected as the winner of the “Best Mobile App for Patient Engagement” in the ninth-annual MedTech Breakthrough Awards program.
IQVIA’s breakthrough Health Research Sp...
Themefolio
Profiler
Peergroup
© BusinessWire
11.06.2025
IQV
LISTED
NYSE
IQVIA Launches New AI Agents for Life Sciences and Healthcare
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, unveils AI agents at GTC Paris. IQVIA’s new custom-built AI agents using NVIDIA technology are designed to enhance workflows and accelerate insights for life sciences. These live...
Themefolio
Profiler
Peergroup
© BusinessWire
02.06.2025
IQV
LISTED
NYSE
IQVIA Announces Pricing of Senior Notes
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2032 (the “Notes”). The proceeds from the Notes offering will be used to repay existing borrowings under the Issuer’s revolving credit facility...
Themefolio
Profiler
Peergroup
© BusinessWire
02.06.2025
IQV
LISTED
NYSE
IQVIA Announces Offering of Senior Notes
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $2,000,000,000 through an offering of senior notes due 2032 (the “Notes”).
The proceeds from the Notes offering will be used to repay existing borrowings under the Issuer’s revolving credit facility and to pay fe...
Themefolio
Profiler
Peergroup
© PR Newswire
27.05.2025
IQV
LISTED
NYSE
Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF
News Preview
Trial is evaluating the safety, tolerability, and efficacy of LTI-03 in idiopathic pulmonary fibrosis (IPF) with topline interim data expected in the first half of 2026
AUSTIN, Texas, May 27, 2025 /PRNewswire/ -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to addres...
Themefolio
Profiler
Peergroup
© BusinessWire
16.05.2025
IQV
LISTED
NYSE
IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has announced a strategic collaboration with the contract research organization arm of Sarah Cannon Research Institute, SCRI Development Innovations, aimed at transforming oncolo...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
IQV
LISTED
NYSE
IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Annual Health Care Conference on Tuesday, May 13, 2025, at 5:20 p.m. ET (2:20 p.m. local PT).
A live audio webcast of the presentation will be available on the IQVIA Investor Relation...
Themefolio
Profiler
Peergroup
© BusinessWire
06.05.2025
IQV
LISTED
NYSE
IQVIA Reports First-Quarter 2025 Results
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended March 31, 2025.
First-Quarter 2025 Operating Results
Revenue for the first quarter of $3,829 mill...
Themefolio
Profiler
Peergroup
© BusinessWire
28.04.2025
IQV
LISTED
NYSE
IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards
News Preview
IQVIA™ (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Marie E. Lamont, head of Real World Solutions (Patient Insights, Experience and Registry Solutions), and Dr. Joanne Hackett, vice president, Health System S...
Themefolio
Profiler
Peergroup
© BusinessWire
23.04.2025
IQV
LISTED
NYSE
IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced today that the global independent research and analysis firm Everest Group® has named IQVIA a “front-runner generative AI leader” for the life sciences industry in its recent report, “AI-deas to Action: Operationali...
Themefolio
Profiler
Peergroup
© BusinessWire
21.04.2025
IQV
LISTED
NYSE
IQVIA to Announce First-Quarter 2025 Results on May 6, 2025
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2025 financial results before the market opens on Tuesday, May 6, 2025. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA I...
Themefolio
Profiler
Peergroup
© BusinessWire
06.02.2025
IQV
LISTED
NYSE
IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended December 31, 2024.
"IQVIA delivered excellent fourth quarter performance, closing out a strong 20...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2025
IQV
LISTED
NYSE
IQVIA named to the Fortune® World’s Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2025 Fortune® World’s Most Admired Companies™ list. This is the fourth year in a row IQVIA has earned first place in the Health Care: Pharmacy and Other Services category, and the eighth...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2025
IQV
LISTED
NYSE
IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its fourth-quarter and full-year 2024 financial results before the market opens on Thursday, February 6, 2025. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2025
IQV
LISTED
NYSE
IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights, and healthcare intelligence, today announced a strategic collaboration with NVIDIA to help realize the potential of AI in healthcare and life sciences.
The healthcare and life sciences industries generate vast amounts of data, representing significant...
Themefolio
Profiler
Peergroup
© BusinessWire
23.12.2024
IQV
LISTED
NYSE
Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute
News Preview
Despite a drop in venture funding for digital health companies over the last two-and-a-half years, digital health products and solutions are expanding in scope and function to aid patient diagnosis, treatment, and monitoring. More solutions are now focused on specific diseases, and their commercial appeal has grown as developers build solutions th...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2024
IQV
LISTED
NYSE
IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the UBS Healthcare Conference in Rancho Palos Verdes, California on Wednesday, November 13, 2024 at 1:15 p.m. ET.
A live audio webcast of the presentation will be available on the IQVIA Investor Relation...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2024
IQV
LISTED
NYSE
IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended September 30, 2024.
Third-Quarter 2024 Operating Results
Revenue for the third quarter of $3,896 m...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2024
IQV
LISTED
NYSE
IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the I...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2024
IQV
LISTED
NYSE
IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today introduces IQVIA AI Assistant, a generative AI technology that enables a step-change enhancement in how life science customers receive timely and powerful insights.
IQVIA...
Themefolio
Profiler
Peergroup
© BusinessWire
19.09.2024
IQV
LISTED
NYSE
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
News Preview
IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that Frost & Sullivan, a leading independent research and consulting firm, has awarded IQVIA with the 2024 Global Customer Value Leadership Award for excellence in the global art...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2024
IQV
LISTED
NYSE
Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative
News Preview
PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today it has joined IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, in its One Home for Sites™ initiative.
IQVIA One Home...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2024
IQV
LISTED
NYSE
Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative
News Preview
PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today it has joined IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, in its One Home for Sites™ initiative.
IQVIA One Home...
Themefolio
Profiler
Peergroup
© BusinessWire
21.08.2024
IQV
LISTED
NYSE
IQVIA CFO Ron Bruehlman to Speak at the Morgan Stanley Annual Global Healthcare Conference on September 4, 2024
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Morgan Stanley Annual Healthcare Conference in New York on Wednesday, September 4, 2024 at 10:00 a.m. ET.
A live audio webcast of the presentation will be available on the IQVIA Investor Relations w...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
